Authors and Disclosures
Benjamin Cohen1, Ashwin N. Ananthakrishnan2, Edward L. Barnes3, Abhik Bhattacharya4, Jean-Frederic Colombel4, Raymond K. Cross5, Marcia S. Driscoll6, Anthony P. Fernandez7, Christina Ha8, Hans Herfarth3, Sara Horst9, Jason Hou10, M. Elaine Husni11, Daniela Kroshinsky12, Kristine A. Kuhn13, Careen Y. Lowder14, George Martin15, Deep Parikh16, Christopher J. Sayed17, Lisa Schocket18, Bernadette C. Siaton19, Priyanka Vedak17, Michael H. Weisman20 and Florian Rieder1
1Department of Gastroenterology and Hepatology, Cleveland Clinic Foundation, Cleveland, OH, USA
2Department of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA
3Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA
4Department of Gastroenterology, Mount Sinai, New York, NY, USA
5Department of Medicine, Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, MD, USA
6Department of Dermatology, University of Maryland, Baltimore, MD, USA
7Department of Dermatology, Cleveland Clinic Foundation, Cleveland, OH, USA
8Department of Gastroenterology, Mayo Clinic Arizona, Scottsdale, AZ, USA
9Department of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, TN, USA
10Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center & Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, TX, USA
11Department of Rheumatologic and Immunologic Disease, Cleveland Clinic Foundation, Cleveland, OH, USA
12Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA
13Department of Medicine, Division of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
14Cleveland Clinic Foundation Cole Eye Institute, Cleveland, OH, USA
15Dr. George Martin Dermatology Associates, Kihei, HI, USA
16Department of Ophthalmology New York Eye and Ear Infirmary of Mount Sinai, Department of Ophthalmology, New York University Langone Health, New York, NY, USA
17Department of Dermatology, University of North Carolina, Chapel Hill, NC, USA
18Department of Ophthalmology, University of Maryland, Baltimore, MD, USA
19Division of Rheumatology and Clinical Immunology, University of Maryland, Baltimore, MD, USA
20Department of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, USA
Correspondence
Florian Rieder, Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, 9500 Euclid Avenue –NC22, Cleveland, OH 44195, USA. Email: riederf@ccf.org
Author Contributions
Katherine Falloon: Conceptualization (equal); data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); project administration (equal); validation (equal); visualization (equal); writing – original draft (lead); writing – review and editing (equal). Benjamin L. Cohen: Conceptualization (equal); data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); project administration (equal); supervision (equal); validation (equal); visualization (equal); writing – original draft (supporting); writing – review and editing (equal). Ashwin Ananthakrishnan: Data curation (equal); formal analysis (equal); methodology (equal); writing – review and editing (equal). Edward L. Barnes: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Abhik Bhattacharya: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Jean-Frederic Colombel: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Raymond K. Cross: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Marcia S. Driscoll: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Anthony P. Fernandez: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Christina Ha: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Hans Herfarth: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Sara Nicole Horst: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Jason Hou: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). M. Elaine Husni: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Daniela Kroshinsky: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Kristine A. Kuhn: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Careen Y. Lowder: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). George Martin: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Deep Parikh: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Christopher J. Sayed: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Lisa Schocket: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Bernadette C. Siaton: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Priyanka Vedak: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Michael H. Weisman: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing – review and editing (equal). Florian Rieder: Conceptualization (lead); data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); project administration (equal); resources (equal); supervision (lead); validation (equal); visualization (equal); writing – original draft (equal); writing – review and editing (lead).
All authors participated in the modified Delphi consensus panel. KF and FR wrote the manuscript. All authors revised and edited the manuscript. All authors approved the final version of the article, including the authorship list.
Declaration of personal interests
AA has served on the scientific advisory boards of Gilead, Ikena therapeutics, and Sun Pharma. Ananthakrishnan is supported by grants from the National Institutes of Health, Crohn's and Colitis Foundation, and Chleck Family Foundation. APF is an investigator for Pfizer, Corbus, Mallinckrodt, and Novartis and receives personal research support from Mallinckrodt and Novartis; honorarium from AbbVie, BMS, Novartis, Alexion, UCB, Boeringer-Ingelheim, and Mallinckrodt for consulting and advisory board participation, and honorarium from AbbVie, Novartis, Kyowa Kirin, and Mallinckrodt for teaching and speaking. ELB is a consultant for AbbVie, Gilead, Pfizer, and Target RWE. BLC receives the following financial support: Advisory Boards and Consultant for Abbvie, Celgene-Bristol Myers Squibb, Pfizer, Sublimity Therapeutics, Takeda, TARGET RWE; CME Companies: Cornerstones, Vindico; Speaking: Abbvie; Educational Grant: Pfizer. RKC receives income from consulting and participation in advisory boards from Abbvie, Bristol Myers Squibb, Eli Lilly, Janssen, Pfizer, Samsung Bioepis, and Takeda. JFC reports receiving research grants from AbbVie, Janssen Pharmaceuticals, and Takeda; receiving payment for lectures from AbbVie, Amgen, Allergan, Inc., Ferring Pharmaceuticals, Shire, and Takeda; receiving consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol Myers Squibb, Celgene Corporation, Eli Lilly, Ferring Pharmaceuticals, Galmed Research, Glaxo Smith Kline, Geneva, Iterative Scopes, Janssen Pharmaceuticals, Kaleido Biosciences, Landos, Otsuka, Pfizer, Prometheus, Sanofi, Takeda, TiGenix; and hold stock options in Intestinal Biotech Development. KF is supported by a grant from the Crohn's and Colitis Foundation. CH is on the advisory board for Abbvie, Janssen, Genentech, InDex Pharmaceuticals, Takeda, Pfizer, and Bristol Myers Squibb. She has research collaborations (nonfunded) with Abbvie, Genentech, Lilly, and Pfizer. She receives grant support from Pfizer. She is on the speakers' bureau for Abbvie. HH receives research support from Allakos, Artizan, NovoNordisk, Pfizer, and consulting fees from Alivio, BMS, Boehringer, ExeGi Pharma, Finch, Gilead, Janssen, Pfizer, Pure Tech, and Otsuka. SH has served as a consultant for Abbvie, Janssen, UCB, Takeda, and Gilead. JH has received research funding from Redhill Biosciences, Janssen, Abbvie, Celgene, Genentech, Eli-Lily, Lycera, and Pfizer Inc. JH is supported in part by resources at the VA HSR&D Center for Innovations in Quality, Effectiveness and Safety (#CIN 13–413), at the Michael E. DeBakey VA Medical Center, Houston, TX. The views expressed in this article are those of the author(s) and do not necessarily represent the views of the Department of Veterans Affairs. GRM serves on Scientific Advisory Boards for Almirall, Incyte, Pfizer, Lilly, UCB, Dermavent, Trevi, Abbvie, Bristol Meyers Squibb (BMS), Celgene, and LEO; is a consultant for Pfizer, Almirall, Abbvie, Lilly, Biofrontera, UCB, Galderma, Scientist, Dermavent, Bausch/Ortho, Incyte, BMS, Celgene, and LEO; is a speaker for Incyte, UCB, LEO; and owns stock in Doc Martins of Maui Sunscreen Company. FR is on the advisory board for or consultant to Adnovate, Agomab, Allergan, AbbVie, Arena, Boehringer Ingelheim, Celgene/BMS, CDISC, Cowen, Ferring, Galmed, Genentech, Gilead, Gossamer, Guidepoint, Helmsley, Index Pharma, Jannsen, Koutif, Mestag, Metacrine, Morphic, Organovo, Origo, Pfizer, fPliant, Prometheus Biosciences, Receptos, RedX, Roche, Samsung, Surmodics, Surrozen, Takeda, Techlab, Theravance, Thetis, UCB, Ysios, and 89Bio. FR is supported by grants from the National Institutes of Health (K08DK110415 and R01DK123233), Crohn's and Colitis Foundation, Rainin Foundation, and the Helmsley Charitable Trust through the Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. CS has received honoraria as a speaker from Abbvie and Novartis, honoraria for consulting from Abbvie, Novartis, and UCB. Investigator fees are paid to the institution by Abbvie, Novartis, UCB, InflaRx, Incyte, and Chemocentryx. Consulting fees are paid to the institution by UCB.